Skip to main content
Axial Podcast

R&D Partnering with Kevin Leland

48 min episode · 2 min read
·
Kevin Leland

Episode

48 min

Read time

2 min

Topics

Career Growth, Relationships, Startups

AI-Generated Summary

Key Takeaways

  • Bootstrapping a two-sided marketplace: Solve the chicken-and-egg problem by identifying "power nodes" — university tech transfer offices, corporate relations officers, and accelerators — who already know which researchers match specific technical needs. Halo's first 300 scientist sign-ups came entirely through a single NACRO newsletter, not paid acquisition, by embedding within existing trusted distribution channels.
  • Proposal design for conversion: Researchers spend roughly 40% of their time on grant paperwork. Halo reduced this to approximately one hour by standardizing five universal questions — hypothesis, rationale, validation, and relevant publications/patents/grants — across all corporate partners, functioning as a common application regardless of industry sector or company size.
  • First customer shapes platform trajectory unexpectedly: Baxter's water purification challenge attracted chemical engineers and material scientists, not biotech specialists. That initial talent pool directly enabled landing Pepsi as a second customer for sustainable packaging work — demonstrating that scientific expertise crosses industry boundaries in non-obvious ways that can expand total addressable market.
  • AI matching beyond keyword tagging: Rather than relying on self-reported expertise, Halo's RoboScout tool scans patent, publication, and grant databases across millions of data points to identify relevant researchers proactively. The next stage involves training proprietary LLMs on internal proposal data — which Leland describes as the real competitive asset — to surface non-obvious researcher-company matches.
  • Corporate accelerators as a scalable growth channel: Halo launched a marketplace for corporate-sponsored incubators, starting with Bayer's CoLab network across Cambridge, Kobe, Shanghai, and Berlin. Startups apply once using existing profiles to multiple programs simultaneously, while companies like BASF and PepsiCo are in discussions to list their accelerators, creating a recurring pipeline beyond one-off sponsored research agreements.

What It Covers

Kevin Leland, founder and CEO of Halo.science, explains how his AI-powered platform connects academic researchers and science-led startups with corporate R&D teams. Starting from a failed crowdfunding concept, Halo evolved into a sector-agnostic marketplace modeled on LinkedIn, now partnering with Bayer, Pepsi, and Baxter.

Key Questions Answered

  • Bootstrapping a two-sided marketplace: Solve the chicken-and-egg problem by identifying "power nodes" — university tech transfer offices, corporate relations officers, and accelerators — who already know which researchers match specific technical needs. Halo's first 300 scientist sign-ups came entirely through a single NACRO newsletter, not paid acquisition, by embedding within existing trusted distribution channels.
  • Proposal design for conversion: Researchers spend roughly 40% of their time on grant paperwork. Halo reduced this to approximately one hour by standardizing five universal questions — hypothesis, rationale, validation, and relevant publications/patents/grants — across all corporate partners, functioning as a common application regardless of industry sector or company size.
  • First customer shapes platform trajectory unexpectedly: Baxter's water purification challenge attracted chemical engineers and material scientists, not biotech specialists. That initial talent pool directly enabled landing Pepsi as a second customer for sustainable packaging work — demonstrating that scientific expertise crosses industry boundaries in non-obvious ways that can expand total addressable market.
  • AI matching beyond keyword tagging: Rather than relying on self-reported expertise, Halo's RoboScout tool scans patent, publication, and grant databases across millions of data points to identify relevant researchers proactively. The next stage involves training proprietary LLMs on internal proposal data — which Leland describes as the real competitive asset — to surface non-obvious researcher-company matches.
  • Corporate accelerators as a scalable growth channel: Halo launched a marketplace for corporate-sponsored incubators, starting with Bayer's CoLab network across Cambridge, Kobe, Shanghai, and Berlin. Startups apply once using existing profiles to multiple programs simultaneously, while companies like BASF and PepsiCo are in discussions to list their accelerators, creating a recurring pipeline beyond one-off sponsored research agreements.

Notable Moment

Leland obtained free entry to $4,000 biotech conferences by securing press passes through a personal blog and volunteering. He would remove his volunteer T-shirt when networking to avoid being perceived as staff — a low-cost tactic that generated Halo's earliest corporate relationships.

Know someone who'd find this useful?

Episode Transcript

Welcome to the Axial podcast. Axial is an early stage investment firm based in San Francisco. We partner with great founders and inventors investing in early stage life science companies often when they are no more than an idea. Axial is fanatical about helping the right venture who's compelled to build their own and journey business. Kevin, we really appreciate you taking the time to do this podcast. I'm really excited to talk about your story and Halo. Maybe to start off with you introduction yourself and what Halo does. Sounds good. Yeah. It's great to be here, Josh. I'm Kevin Leland, the founder and CEO of of halo.science. We are an AI powered platform for scientific innovators. We help, scientists and science led startups connect directly with corporate r and d teams to collaborate and, bring their innovations to market. And so what's the overarching, like, mission of Halo? Is there, like, a North Star goal, like accelerate science or something that kind of drives the whole company forward? Yeah. Well, I would you know, our overarching mission is is move science forward, which is just three words, but there's so many things that are standing in the way of moving science forward. And one of those is just simply making the the right connections between the the science with the the technology or expertise and the the companies that can actually turn it into something commercial. And so that kinda translates into everything that we do at Halo to remove that friction so more science can be commercialized. The vision of Halo was really to do for r and d partnering what, LinkedIn did for, recruiting and job searching. Absolutely. And, you know, how do you how do you think about building that network, of not only partners and corporates and cost and and, you know, large companies and scientists and ventures? And how do you go about how did you go about, like, bootstrapping that network, and where did you start? Great question. So where I started was well, why don't we go back a little bit further maybe? I don't know. I'll I'll tell you about the origin of of Halo, which isn't exactly what it is right now, but it will kinda lead into answering that question. So the original idea for Halo was actually different. It was around crowdfunding, research at universities. So, you've probably heard of the valley of death and drug development. You have these promising technologies that, don't need, you know, hundreds of millions of dollars or even millions of dollars. They need a half $1,000,000 to do some derisking project and to kinda get it to the next stage. But, they can't get that $500,000, so they wind up in the proverbial, valley of death. So the idea was, hey. Why don't we tap into alumni at the university and these foundations to, who care about that particular, topic area and then raise that money to fund that project and …

Get the full transcript (8,758 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Axial Podcast transcripts →

You just read a 3-minute summary of a 45-minute episode.

Get Axial Podcast summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

Books, tools, and gear mentioned in this episode

SignalCast may earn commission on purchases via these links.

Tools

  • RoboScoutBy guest
    Halo's RoboScout tool scans patent, publication, and grant databases across millions of data points to identify relevant researchers proactively.

company

  • now partnering with Bayer, Pepsi, and Baxter
  • Halo.scienceBy guest
    Kevin Leland, founder and CEO of Halo.science, explains how his AI-powered platform connects academic researchers and science-led startups with corporate R&D teams.
  • now partnering with Bayer, Pepsi, and Baxter
  • now partnering with Bayer, Pepsi, and Baxter

More from Axial Podcast

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Biotech Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Startups & Product Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Axial Podcast.

Every Monday, we deliver AI summaries of the latest episodes from Axial Podcast and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime